RUNX2 and chondrosarcoma: There have been numerous studies on the anti-inflammatory effects of GPS [18, 19]; however, whether GPS ameliorates inflammation and chondrocyte hypertrophy in the LPS-induced SW 1353 chondrosarcoma cells via the Stat3/Runx2 signaling pathway has not been reported.